Lilly’s Animal Worldwide Revenue Up 12%

Eli Lilly and Co. reported a 12 percent increase in revenue from one year ago.

Eli Lilly and Co.’s Animal Division reported worldwide revenue of $264.1 million in the first quarter ended March 31, an increase of 12 percent over the year-ago period.

U.S. revenue grew by 43 percent, to $153.6 million, primarily due to sales from the Posilac acquisition completed in October.

Revenue outside the U.S. fell by 13 percent, to $110.5 million, primarily because of unfavorable exchange rates, according to the Indianapolis company.

Overall, Lilly reported first-quarter net income of $1.3 billion on revenue of $5 billion, compared to $1.1 billion and $4.8 billion, respectively, in the year-ago period.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.